2025 France Antimicrobial Susceptibility Testing Market Revenue Opportunities Report
Description
The 2025 France Antimicrobial Susceptibility Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antimicrobial Susceptibility Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Antimicrobial Susceptibility Testing (AST) market in France are bioMérieux SA, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., and Bio-Rad Laboratories. BioMérieux, a French company, is a key player recognized for its innovative automated AST systems like VITEK 2 and VITEK MS, which help detect microbial resistance quickly and accurately. BD offers advanced solutions such as BD Phoenix and BD Bruker MALDI Biotyper that provide fast and precise susceptibility profiles to aid clinical decisions. Thermo Fisher Scientific provides broad diagnostic products including the Sensititre and MAS systems for precise antimicrobial resistance detection. Bio-Rad Laboratories specializes in reliable testing solutions like the MRSA-Screen and VITEK 2 Systems to identify resistant strains efficiently.
These companies contribute significantly to the France AST market, which generated approximately USD 122.1 million in 2023 and is expected to grow at a CAGR of 5% to USD 171.7 million by 2030. The market growth is driven by the rising challenge of antimicrobial resistance, leading to high demand for accurate and rapid testing technologies. Automated instruments, where these companies focus, are the most lucrative and fastest-growing segment. Collectively, bioMérieux, Thermo Fisher, and Danaher Corporation hold 60%-65% of the global market share, reflecting their influence in France as well. The presence of bioMérieux’s headquarters in France further strengthens its active role in the local market.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antimicrobial Susceptibility Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Antimicrobial Susceptibility Testing (AST) market in France are bioMérieux SA, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., and Bio-Rad Laboratories. BioMérieux, a French company, is a key player recognized for its innovative automated AST systems like VITEK 2 and VITEK MS, which help detect microbial resistance quickly and accurately. BD offers advanced solutions such as BD Phoenix and BD Bruker MALDI Biotyper that provide fast and precise susceptibility profiles to aid clinical decisions. Thermo Fisher Scientific provides broad diagnostic products including the Sensititre and MAS systems for precise antimicrobial resistance detection. Bio-Rad Laboratories specializes in reliable testing solutions like the MRSA-Screen and VITEK 2 Systems to identify resistant strains efficiently.
These companies contribute significantly to the France AST market, which generated approximately USD 122.1 million in 2023 and is expected to grow at a CAGR of 5% to USD 171.7 million by 2030. The market growth is driven by the rising challenge of antimicrobial resistance, leading to high demand for accurate and rapid testing technologies. Automated instruments, where these companies focus, are the most lucrative and fastest-growing segment. Collectively, bioMérieux, Thermo Fisher, and Danaher Corporation hold 60%-65% of the global market share, reflecting their influence in France as well. The presence of bioMérieux’s headquarters in France further strengthens its active role in the local market.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
